http://neuromuscular.wustl.edu/antibody/pnimdem.html#variant 
| Acute onset β-Tubulin antibodies Childhood CNS features Diabetes IgM vs GM2 & GalNAc-GD1a Motor M-protein: IgM; IgG or IgA Multifocal Upper limb Perineuritis POEMS Sensory Subacute Typical | 
- Multifocal CIDP9- Nosology- Multifocal CIDP
- Lewis-Sumner1
- MADSAM
- Also see: Upper limb CIDP
 
- Age range: 28 to 58 years
- Weakness- Asymmetric
- Distal > Proximal
- Arms > Legs (78%)
- Proximal syndrome: Occasional- Phrenic nerve: Diphragm weakness; Respiratory insufficiency
- Suprascapular nerve: Infraspinatus ± Supraspinatus weakness
- Other scattered distal & proximal muscles
 
 
- Sensory loss: Distal; Pansensory; Rarely severe or disabling
- Tendon reflexes: Focal loss
- Course: Slowly progressive, or Relapsing-Remitting
- Laboratory- Electrophysiology- Multifocal conduction block
- Nerve conduction velocities: Variably slow
- Distal latencies: Variably prolonged
 
- CSF protein: High but usually < 100 mg/dL
- IgM anti-GM1 antibodies: Never
- MRI: Swollen nerves in brachial plexus with high T2 signal
- Nerve pathology
 
- Electrophysiology
- Treatment: Prednisone; HIG
 
- Nosology
- Multifocal upper limb CIDP2,6- Male:Female = 1.9:1
- Onset- Mean = 43 to 54 years; Range 9 to 75 years
- Rarely childhood
- Acute or Progressive
- Distal
 
- Clinical- Weakness- Onset: May be motor, sensory, or both; With reduced pain
- Single or multiple upper extremity nerves
- Distal > Proximal
- Asymmetric > Symmetric
- Monomelic or Bilateral
 
- Sensory- Paresthesias or numbness early in most
- Pain: 22%; Often localized to peripheral nerve territory
- Sensory loss: Usually mild, distal; Often asymmetric
 
- Tendon reflexes: Often reduced in involved limb(s)
- Course- Progressive: To legs in 25%
- Some stabilize or spontaneously resolve
 
- Cranial nerves: 17%; Optic; III; VII
- Rule out: Brachial neuritis
 
- Weakness
- Laboratory- Anti-GM1 ganglioside antibodies: Uncommon
- CSF protein- High in 40% to 72%
- Mean 64 mg/dL; Range 21 to 128
 
- Nerve conduction studies- Conduction block (100%): Proximal or Distal segments
- Slowing 35%;
- CMAP amplitude: Reduced (56%)
- Abnormal SNAPs: Some patients; Up to 83%
- Leg involvement: 34%
 
- MRI- Usually normal
- May have brachial plexus lesions
 
 
- Treatment- Response to Prednisone or HIG in some (> 50%)
- Often less recovery than with generalized CIDP
 
 
- Motor predominant CIDP 36- Clinical- Onset- Age: 8 to 24 years
- Weakness: Progressive over 1 to 6 months
 
- Weakness- Distal > Proximal
- Symmetric
- Arm predominant or Arms & Legs
- May be exacerbated by heat (Uhthoff-like phenomenon)
 
- Sensory exam: Normal
- Tendon reflexes: Diffusely absent
 
- Onset
- Laboratory- Nerve conduction studies- Motor: Distal & F-wave latency long; Conduction block; NCV slowed (17 to 33 M/s
- Sensory: Normal or reduced SNAP amplitudes
 
- CSF: Protein high
- GM1 antibodies: Not present
 
- Nerve conduction studies
- Differential diagnosis: Multifocal motor neuropathy
 
- Clinical
- Sensory CIDP- Clinical- Sensory- Loss: Distal predominant; Pansensory or Small fiber
- Pain
 
- Motor: Normal or minimal distal weakness
- Tendon reflexes: Normal or Reduced
 
- Sensory
- Electrophysiology (NCV): Motor & Sensory demyelination- Motor- Conduction block
- NCV: Slow
- Distal latency: Long
 
- Sensory: Slow NCV
 
- Motor
- Treatment: Poor response to prednisone or HIG
 
- Clinical
- Childhood CIDP- Prevalence: ~ 1 in 300,000; Male > Female
- Preceding infections or vaccinations: 54%
- Onset: Childhood to Teens; Rarely infancy
- Course: Several patterns- Monophasic: 25%- Peak disability < 3 months
- Off medications in < 1 year
 
- Chronic- Persistent weakness & disability
- Require continued immunosuppression
 
- Acute onset: 25%
- Relapsing: Often treatment related
 
- Monophasic: 25%
- Clinical patterns- Overall
- Weakness: Proximal + Distal; Usually symmetric
- Sensory loss: Pansensory; Distal; Symmetric
- Tendon reflexes: Reduced or Absent
- Other: Rare clinical CNS features
 
- Disease Associations- Comparison with adult CIDP: Less with M-proteins & Diabetes
- CNS changes: Rarely reported19
- Other systems: Renal; Hearing28
 
- Prognosis- Better for remission with relatively rapid onset
- Worse: Axonal loss
 
- Laboratory- Pathology- Similar to adult CIDP
- Chronic cases may have prominent demyelinating features
 
- MRI: Gadolinium enhancement of roots very common; Occasional CNS changes
- Nerve conduction: Similar to adult CIDP
 
- Pathology
- Treatment- Corticosteroids: Response in > 90%
- IVIg: Response in > 80%
- Methotrexate: 2nd line treatment
 
 
- CIDP + IgM M-protein vs β-tubulin- Weakness: Slowly progressive; Asymmetric
- Hyporeflexia
- Poor response to prednisone
- Antigenic epitope: β-tubulin amino acids 301-314
 
- CIDP associated with IgG or IgA M-protein- Similar clinical syndrome to typical CIDP
- Weakness: Slowly progressive; Symmetric
- Partial response to immunotherapy
 
- CIDP + Diabetes mellitus8- Patient characteristics: Most similar to CIDP alone
- Differences from CIDP- Age: Older (67 years)
- Symptoms: More gait imbalance
- Electrodiagnostic: More axonal loss
- Treatment: Less improvement
 
 
- CIDP: Acute onset32- Onset: Progressive over days to weeks
- Clinical- Weakness- Symmetric
- Proximal & Distal
- Uncommon: Face, Tongue, Eye movements, Respiratory failure
- Less severe than GBS
 
- Sensory loss: Distal
- Tendon reflexes: Reduced
- Course- Slower progression to nadir than GBS
- Partial, but not complete improvement in strength over months
- Treatment related exacerbations- Common
- Time of first exacerbation: Median 18 days; Range 10 to 54 days
- Especially > 8 weeks after onset
- May occur ≥ 3 times
 
 
 
- Weakness
- Laboratory- Electrodiagnostic- Prominent demyelinating features early in disease course
- More slowing of motor nerve conduction velocity than GBS
- Conduction block (30%)
- EMG denervation (75%)
 
- CSF protein: High
- Antibodies: IgG anti-glycolipid uncommon
 
- Electrodiagnostic
 
- CIDP: Subacute onset23- Male > Female: 2 to 1
- Onset- Age: Childhood or Adult
- Progressive over 4 to 8 weeks
- Antecedent infection (38%)
 
- Clinical- Weakness (80%)- Symmetric (90%)
- Proximal & Distal
 
- Sensory loss (80%): Distal
- Tendon reflexes: Reduced
- Course- Improvement with corticosteroid treatment
- Few relapses
 
 
- Weakness (80%)
- Laboratory- Electrodiagnostic: Demyelination- NCV: Slow
- Terminal latency: Prolonged (50%)
- Conduction block: 50%
- Temporal dispersion: 50%
- Sensory: Absent SNAPs
 
- CSF protein: High
- Nerve biopsy- Demyelination in some: May require teased fibers to document
- Inflammation: Epineurial; Some patients
 
 
- Electrodiagnostic: Demyelination
 
- CIDP + CNS features19- Frequency: Rare patients with CNS features
- Onset
- CNS features- Ocular- Papilledema: Associated with high CSF protein
- Visual loss: Optic atrophy
 
- Myelopathy- Tendon reflexes may be brisk
- r/o Spinal cord compression from enlarged nerve roots
 
- Ataxia
- Focal CNS myelin loss: 1 patient- CNS: Focal mass-like lesion
- Weakness: Mild; Distal
- Sensory loss: Mild vibration
- Tendon reflexes: Normal
- NCV: Slow; Long distal latency
 
- Multiple sclerosis + CIDP27- MS duration at onset: 4 to 22 years
- Clinical- Weakness: Distal > Proximal;
- Sensory loss: Distal; Pan-modal
- Tendon reflexes: Reduced or Absent
 
- CSF protein: > 120 mg/dL
- Nerve conduction studies: Demyelinating neuropathy
- Treatment: IVIg; Corticosteroids
 
 
- Ocular
- Rule out: Late onset dysmyelination (MLD; Krabbe)
- Treatment: Corticosteroids
 
- Perineuritis- Usually axonal neuropathy: Occcasional demyelinating neuropathy reported
 
 
No comments:
Post a Comment